Justin Bria, MD | |
4201 Saint Antoine St, Detroit, MI 48201-2153 | |
(313) 745-5146 | |
Not Available |
Full Name | Justin Bria |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 4201 Saint Antoine St, Detroit, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881214435 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 4301510307 (Michigan) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Justin Bria, MD 4201 Saint Antoine St, Detroit, MI 48201-2153 Ph: () - | Justin Bria, MD 4201 Saint Antoine St, Detroit, MI 48201-2153 Ph: (313) 745-5146 |
News Archive
A new guideline published recently by the Standards of Care Committee of the British Society for Allergy & Clinical Immunology (BSACI) aims to bring together the latest science in order to improve the diagnosis and management of peanut and tree nut allergy.
Based on projected increases in the prevalence of diabetes, the number of people with diabetes-related retinal disease, with glaucoma and with cataracts is estimated to increase significantly by 2050, according to a report in the December issue of Archives of Ophthalmology.
In California and North Carolina, local programs that help undocumented workers and the uninsured get care - often without using federal funds - are detailed.
A researcher who found that testosterone raised the risk of prostate tumors and exacerbated the effects of carcinogenic chemical exposure in rats is urging caution in prescribing testosterone therapy to men who have not been diagnosed with hypogonadism, according to a new study published in the Endocrine Society's journal Endocrinology.
China Ruitai International Holdings Co., Ltd., a manufacturer and distributor of cellulose ether additives for use in the production of pharmaceuticals, construction materials, PVC products, foods and beverages and cosmetics, today announced its results for the three months ended March 31, 2011.
› Verified 6 days ago